ONMD underwent significant financial restructuring with a 70% increase in outstanding shares, massive debt reduction of 90.5%, and substantial improvement in equity position despite continued operational losses.
The 70% increase in shares outstanding (from 30.8M to 52.2M) combined with the June 2025 private placement with James Sixsmith indicates significant dilution but also fresh capital injection. The dramatic reduction in total debt from $2.3M to $220K and improvement in stockholders' equity from -$15.9M to -$3.0M suggests a major balance sheet restructuring that has stabilized the company's financial position in the near term.
ONMD's financials show a company emerging from financial distress through equity financing and debt restructuring. While revenue doubled from $643K to $1.4M, gross losses also increased significantly, and the company remains unprofitable with rising interest expenses. However, the dramatic 90.5% debt reduction, 81.4% improvement in stockholders' equity, and substantial decrease in current liabilities from $19.2M to $4.8M indicate successful financial restructuring that has bought the company time to execute its turnaround strategy, albeit at the cost of significant shareholder dilution.
Cash position surged 240.1% — strong cash generation or capital raise providing significant financial cushion.
Receivables surged 132.4% — revenue recognized but not yet collected; watch for collection issues or channel stuffing.
Strong top-line growth of 111.4% — accelerating demand or successful expansion into new markets.
Debt reduced 90.5% — deleveraging strengthens balance sheet and reduces financial risk.
Interest expense surged 85.8% — significant debt increase or rising rates materially impacting earnings.
Equity base grew 81.4% — retained earnings accumulation or equity issuance strengthening the balance sheet.
Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.
Current liabilities reduced — improved short-term financial position and working capital health.
Capex reduced 74.5% — investment cycle winding down or capital discipline; may improve near-term free cash flow.
Liabilities reduced 74% — deleveraging improves balance sheet strength and financial flexibility.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →